D.E. Shaw & Co’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-71,478
| Closed | -$4.85M | – | 4298 |
|
|
2019
Q3 | $4.85M | Sell |
71,478
-215,241
| -75% | -$14.8M | 0.01% | 1673 |
|
|
2019
Q2 | $16.7M | Buy |
286,719
+116,891
| +69% | +$6.92M | 0.02% | 844 |
|
|
2019
Q1 | $11.9M | Sell |
169,828
-75,712
| -31% | -$5.61M | 0.02% | 1000 |
|
|
2018
Q4 | $15.8M | Buy |
245,540
+145,547
| +146% | +$10.2M | 0.02% | 812 |
|
|
2018
Q3 | $7.02M | Sell |
99,993
-83,629
| -46% | -$4.89M | 0.01% | 1332 |
|
|
2018
Q2 | $9.25M | Buy |
183,622
+96,466
| +111% | +$3.83M | 0.01% | 1123 |
|
|
2018
Q1 | $2.73M | Sell |
87,156
-30,133
| -26% | -$1,000K | ﹤0.01% | 1825 |
|
|
2017
Q4 | $4.01M | Buy |
117,289
+18,516
| +19% | +$590K | 0.01% | 1641 |
|
|
2017
Q3 | $3.17M | Sell |
98,773
-6,597
| -6% | -$208K | ﹤0.01% | 1717 |
|
|
2017
Q2 | $3.43M | Buy |
105,370
+33,792
| +47% | +$1.07M | 0.01% | 1617 |
|
|
2017
Q1 | $2.25M | Buy |
71,578
+15,601
| +28% | +$462K | ﹤0.01% | 1768 |
|
|
2016
Q4 | $1.65M | Sell |
55,977
-25,538
| -31% | -$779K | ﹤0.01% | 2145 |
|
|
2016
Q3 | $2.36M | Buy |
81,515
+9,314
| +13% | +$260K | ﹤0.01% | 1806 |
|
|
2016
Q2 | $1.87M | Buy |
72,201
+14,562
| +25% | +$387K | ﹤0.01% | 1981 |
|
|
2016
Q1 | $1.43M | Buy |
57,639
+48,824
| +554% | +$1.34M | ﹤0.01% | 2118 |
|
|
2015
Q4 | $310K | Sell |
8,815
-40,922
| -82% | -$1.1M | ﹤0.01% | 3354 |
|
|
2015
Q3 | $1.05M | Buy |
49,737
+2,400
| +5% | +$61.8K | ﹤0.01% | 2572 |
|
|
2015
Q2 | $1.31M | Buy |
47,337
+19,764
| +72% | +$557K | ﹤0.01% | 2507 |
|
|
2015
Q1 | $842K | Buy |
27,573
+15,489
| +128% | +$492K | ﹤0.01% | 2696 |
|
|
2014
Q4 | $386K | Buy |
12,084
+716
| +6% | +$23.3K | ﹤0.01% | 3499 |
|
|
2014
Q3 | $322K | Sell |
11,368
-2,832
| -20% | -$79K | ﹤0.01% | 3647 |
|
|
2014
Q2 | $389K | Buy |
+14,200
| New | +$378K | ﹤0.01% | 3699 |
|
|
2013
Q3 | – | Sell |
-7,500
| Closed | -$238K | – | 4540 |
|
|
2013
Q2 | $238K | Buy |
+7,500
| New | +$246K | ﹤0.01% | 3690 |
|
D.E. Shaw & Co's GHDX Position: Q4 2019 in Review
D.E. Shaw & Co sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 71,478 shares — an estimated $4.85M sold.
D.E. Shaw & Co first reported a position in GHDX in Q2 2013 and held it in 23 quarters. The position peaked at $16.7M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- D.E. Shaw & Co reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- D.E. Shaw & Co sold 71,478 Genomic Health, Inc. shares in Q4 2019, an estimated $4.85M.
- D.E. Shaw & Co first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 23 quarters.
- D.E. Shaw & Co's Genomic Health, Inc. position peaked at $16.7M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.